Snake venom metalloproteinases are predominantly responsible for the cytotoxic effects of certain African viper venoms
Keirah E. BartlettiD, Adam WesthorpeiD, Mark C. WilkinsoniD, Nicholas R. CasewelliD
Abstract
AbstractSnakebite envenoming is a neglected tropical disease that causes substantial mortality and morbidity globally. The puff adder (Bitis arietans) and saw-scaled viper (Echis romani) have cytotoxic venoms that cause permanent injury via tissue-destructive dermonecrosis around the bite site. Identification of cytotoxic toxins within these venoms will allow development of targeted treatments, such as small molecule inhibitors or monoclonal antibodies to prevent snakebite morbidity. Venoms from both species were fractionated using gel filtration chromatography, and a combination of cell-based cytotoxicity approaches, SDS-PAGE gel electrophoresis, and enzymatic assays were applied to identify venom cytotoxins in the resulting fractions. Our results indicated that snake venom metalloproteinase (SVMP) toxins are predominately responsible for causing cytotoxic effects across both venoms, but that the PII subclass of SVMPs are likely the main driver of cytotoxicity following envenoming by B. arietans, whilst the structurally distinct PIII subclass of SVMPs are responsible for conveying this effect in E. romani venom. Identification of distinct SVMPs as the primary cytotoxicity-causing toxins in these two African viper venoms will facilitate the future design and development of novel therapeutics targeting these medically important venoms, which in turn could help to mitigate the severe life and limb threatening consequences of tropical snakebite. Key ContributionSVMP toxins were identified as the primary cytotoxicity-causing toxins in the venoms of the puff adder (Bitis arietans) and saw-scaled viper (Echis romani); PII and PIII SVMPs, respectively. This cytotoxicity can be prevented using the metalloproteinase-inhibiting chelator EDTA, suggesting targeted drugs/antibodies may be a viable option for future treatment.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- FWCI
- 1.57
- Field percentile
- top 18%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Natures Antivenom: Combinations of conserved rattlesnake serum metalloproteinase inhibitors block the lethal action of viper venoms
Sean B. Carroll, Fiona P. Ukken, … Elda Eliza Sanchez·Proceedings of the National Academy of SciencesPeer-reviewed·Jul 29, 2026
- Complex compositional and functional diversity of venom metalloproteinases in African puff adders
Mark C. Wilkinson, Cassandra M. Modahl, … Nicholas R. Casewell·bioRxiv·May 31, 2024
- Preclinical validation of a repurposed metal chelator as a community-based therapeutic for hemotoxic snakebite
L.-O. Albulescu, M. Hale, … N. R. Casewell·bioRxiv·Jul 28, 2019
- A combination of two small molecule toxin inhibitors provides pancontinental preclinical efficacy against viper snakebite
L.-O. Albulescu, C. Xie, … N. R. Casewell·bioRxiv·May 13, 2020
- Neutralizing effects of small molecule inhibitors and metal chelators on coagulopathic Viperinae snake venom toxins
C. Xie, L. Albulescu, … J. Kool·bioRxiv·Jun 2, 2020
- Echis carinatus snake venom metalloprotease-induced toxicities in mice: therapeutic intervention by a repurposed drug, tetraethylthiuram disulfide (disulfiram)
G. V. Rudresha, A. P. Urs, … B. Vishwanath·bioRxiv·Jul 17, 2020